Testing gene editing techniques in pigs for biomedical research
Official title: Coordination: Swine Somatic Cell Gene Editing Testing Center
Funded at University of Missouri-Columbia · NIH-10928243 · Data updated 2026-11-12
This study is working on using gene editing in pigs to create better models for understanding human diseases and finding new treatments, and it involves teamwork among researchers and regulators to ensure everything is done safely and effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | September 12, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $248,599 |
| NIH project number | 5U42OD035738-02 |
| Project ID | NIH-10928243 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include those involved in biomedical research and gene editing technologies.
✕Less likely to help
Patients who are not involved in biomedical research or do not have a direct interest in gene editing technologies may not receive benefit from this research.
What this research studies
This research focuses on coordinating efforts to test somatic cell gene editing techniques in swine, which are important for developing new biomedical models. The project involves managing communication and logistics among various stakeholders, including researchers and regulatory agencies. By refining standard operating procedures and providing testing services, the research aims to assess the safety and efficacy of gene editing reagents in health and disease models. The ultimate goal is to create novel swine models that can help in understanding human diseases and developing new treatments.
Why it matters
Potential benefit: If successful, this research could lead to improved biomedical models that enhance our understanding of human diseases and the development of new therapies.
How similar studies have gone: Other research has shown success with similar gene editing approaches in animal models, indicating potential for this project to yield valuable insights.
Where this research is happening
-
University of Missouri-Columbia
Columbia, United States Active
Researchers
- Principal investigator: Wells, Kevin Dale — University of Missouri-Columbia
- Study coordinator: Wells, Kevin Dale
Related research
Other NIH-funded projects on the same topics.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
Interface between immune cells and scarring in the eye
This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.
-
Understanding cell-cleanup problems in C9ORF72-related ALS/FTD
Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.
-
Molecular clues to endometriosis-related infertility
This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.
-
A universal Shigella vaccine using SAVE to protect people of all ages
A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.
-
Biomarkers that predict osteoarthritis risk in people at higher risk
A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.